Innovating Works

KevadBio

Financiado
Developing a novel Parkinson's disease drug using small molecule mimetics of Gli...
Developing a novel Parkinson's disease drug using small molecule mimetics of Glial cell line-Derived Neurotrophic Factor (GDNF) GeneCode is developing a novel anti-PD drug that contains a central nervous system penetrant compound imitating GDNF peptide pathway activation that alleviates both motor and non-motor symptoms in PD patients, protecting and resto... ver más
31/12/2025
GENECODE AS
2M€
Presupuesto del proyecto: 2M€
ver más
Líder del proyecto
GENECODE AS No se ha especificado una descripción o un objeto social para esta compañía.
Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-11-17
HORIZON-EIC-2023-ACCELERATOROPEN-01: EIC Accelerator Open 2023 Scope:The EIC Accelerator Open has no predefined thematic priorities and is open to proposals in any...
Cerrada hace 1 año
0% 70% 100%